ResGIN-Att predicts drug synergy by extracting multi-scale molecular features with residual GIN, fusing them via LSTM, and modeling interactions with cross-attention, achieving competitive results on five benchmark datasets.
Inference of synergy/antagonism between anticancer drugs from the pooled analysis of clinical trials.BMC Medical Research Methodology, 13(1):77
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
cs.LG 1years
2026 1verdicts
UNVERDICTED 1representative citing papers
citing papers explorer
-
Drug Synergy Prediction via Residual Graph Isomorphism Networks and Attention Mechanisms
ResGIN-Att predicts drug synergy by extracting multi-scale molecular features with residual GIN, fusing them via LSTM, and modeling interactions with cross-attention, achieving competitive results on five benchmark datasets.